BX Swiss TOP 30 CHF
1.228,04
PKT
-12,73
PKT
-1,03
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.02.19 | Nestlé buy | Jefferies & Company Inc. | |
| 14.02.19 | UBS buy | UBS AG | |
| 14.02.19 | Nestlé buy | Goldman Sachs Group Inc. | |
| 14.02.19 | Nestlé buy | UBS AG | |
| 14.02.19 | UBS buy | Goldman Sachs Group Inc. | |
| 14.02.19 | UBS overweight | JP Morgan Chase & Co. | |
| 14.02.19 | Nestlé overweight | JP Morgan Chase & Co. | |
| 14.02.19 | Nestlé buy | Baader Bank | |
| 14.02.19 | UBS buy | UBS AG | |
| 13.02.19 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 13.02.19 | Roche Neutral | UBS AG | |
| 12.02.19 | Nestlé market-perform | Bernstein Research | |
| 12.02.19 | UBS buy | Goldman Sachs Group Inc. | |
| 11.02.19 | Roche overweight | Morgan Stanley | |
| 11.02.19 | Zurich Insurance Neutral | UBS AG | |
| 08.02.19 | Zurich Insurance Outperform | Credit Suisse Group | |
| 07.02.19 | Zurich Insurance Hold | Kepler Cheuvreux | |
| 07.02.19 | Givaudan Neutral | Credit Suisse Group | |
| 07.02.19 | Zurich Insurance Neutral | UBS AG | |
| 07.02.19 | Holcim Neutral | Goldman Sachs Group Inc. | |
| 07.02.19 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 07.02.19 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 06.02.19 | Holcim Sell | UBS AG | |
| 06.02.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 06.02.19 | Novartis Hold | HSBC | |
| 06.02.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 05.02.19 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 04.02.19 | Zurich Insurance buy | Merrill Lynch & Co., Inc. | |
| 04.02.19 | Roche buy | Jefferies & Company Inc. | |
| 04.02.19 | UBS buy | UBS AG | |
| 04.02.19 | UBS buy | Deutsche Bank AG | |
| 04.02.19 | Roche Reduce | HSBC | |
| 04.02.19 | Holcim Hold | HSBC | |
| 04.02.19 | Novartis Hold | Deutsche Bank AG | |
| 01.02.19 | Roche Reduce | HSBC | |
| 01.02.19 | Zurich Insurance Neutral | UBS AG | |
| 01.02.19 | Swiss Re Sell | UBS AG | |
| 01.02.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 01.02.19 | Novartis Underweight | Barclays Capital | |
| 01.02.19 | Roche Neutral | Credit Suisse Group |